Koninklijke Philips (RYLPF) Shares Outstanding (Weighted Average) (2014 - 2025)
Koninklijke Philips (RYLPF) recorded quarterly Shares Outstanding (Weighted Average) of $1.1 billion in Q4 2025, up 11.02% quarter-over-quarter from $997.4 million in Q4 2024, and up 11.02% on a YoY basis from $997.4 million in Q4 2024.
Koninklijke Philips (RYLPF) Shares Outstanding (Weighted Average) (2014 - 2025) Analysis & Trends
Koninklijke Philips' Shares Outstanding (Weighted Average) history runs 12 years deep, the most recent figure standing at $1.1 billion for Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) rose 11.02% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $1.1 billion (up 11.02% YoY), while the FY2025 annual figure was $1.1 billion, up 11.02% from the prior year.
- Shares Outstanding (Weighted Average) was $1.1 billion for Q4 2025 at Koninklijke Philips, up from $997.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.1 billion in Q4 2025 to a low of $189.9 million in Q2 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $648.4 million across 5 years, with a median of $899.3 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) dropped 13.81% in 2022, then grew 13.45% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $995.5 million in 2021, then declined by 9.66% to $899.3 million in 2022, then advanced by 13.45% to $1.0 billion in 2023, then retreated by 2.25% to $997.4 million in 2024, then rose by 11.02% to $1.1 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q4 2025), $997.4 million (Q4 2024), and $202.5 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | 997.40 Mn |
| Jun 30, 2024 | 202.45 Mn |
| Dec 31, 2023 | 1.02 Bn |
| Jun 30, 2023 | 202.54 Mn |
| Dec 31, 2022 | 899.33 Mn |
| Jun 30, 2022 | 189.94 Mn |
| Dec 31, 2021 | 995.46 Mn |
| Jun 30, 2021 | 220.38 Mn |
| Dec 31, 2020 | 1.08 Bn |
| Jun 30, 2020 | 197.16 Mn |
| Dec 31, 2019 | 986.21 Mn |
| Jun 30, 2019 | 203.38 Mn |
| Dec 31, 2018 | 1.04 Bn |
| Jun 30, 2018 | 226.75 Mn |
| Dec 31, 2017 | 1.09 Bn |
| Dec 31, 2016 | 995.98 Mn |
| Dec 31, 2015 | 1.01 Bn |
| Dec 31, 2014 | 1.14 Bn |